In LDL-receptor knockout Leiden mouse models (LDLr−/−) with non-alcoholic fatty liver disease (NAFLD) and obesity, HP-EVOO intake significantly reduced adipose tissue hypertrophy [36,37,38,39,41,42]. The gene discussed is LDLR; the disease is metabolic dysfunction-associated steatotic liver disease.